title: Salbutamol for hyperkalaemia in children.
abstract: Hyperkalaemia is a potentially fatal disorder that demands direct treatment. The efficacy of traditional medical treatment is unpredictable, limited, of short duration or carries the risk of serious adverse events. The administration of salbutamol for hyperkalaemia in children is described in several clinical trials and case reports.
  
  
  CONCLUSIONS
  Salbutamol, inhaled or infused, is safe and efficacious and results in a predictable and long-lasting reduction in serum potassium. Salbutamol merits a place as the preferred medication for hyperkalaemia in children without arrhythmias. If follow-up with haemodialysis is required, the administration of salbutamol gives time to make the necessary preparations.
authors.affiliation: Department of Clinical Pharmacy, Medical Spectrum Twente, The Netherlands. apomst@euronet.nl
authors.forename: E
authors.initials: E
authors.lastname: Helfrich
authors.forename: T W
authors.initials: TW
authors.lastname: de Vries
authors.forename: E N
authors.initials: EN
authors.lastname: van Roon
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000420:Albuterol / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D006947:Hyperkalemia / Q000188:drug therapy* / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000150:complications
chemical_list: D000318:Adrenergic beta-Agonists; D000420:Albuterol